Ironwood Pharma (IRWD) Posts Mixed Q1 Results

Ironwood Pharma (NASDAQ: IRWD) reported Q1 EPS of ($0.34), $0.10 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $12.25 million versus the consensus estimate of $9.48 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Truist upgrades Biogen to Buy on Alzheimer's, pipeline optimism ahead of key data
• T. Rowe Price AUM reaches $1.89 trillion at end of June 2026
• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside